PILOT STUDY OF A CALCIUM CHANNEL BLOCKER IN FEMALES WITH BIPOLARDISORDER NIH Guide, Volume 25, Number 20, June 21, 1996 RFP AVAILABLE: NIMH-96-CR-0006 P.T. 34 Keywords: Psychosis Clinical Trial National Institute of Mental Health The National Institute of Mental Health (NIMH) has a requirement entitled "Pilot Study of a Calcium Channel Blocker in Females with Bipolar Disorder" to (1) determine in the most cost effective manner, preliminary evidence of efficacy for calcium channel blockers such as verapamil in bipolar disorder, and (2) recruit appropriate patients for the trial and enroll, randomize and initiate medication treatment for approximately 10 patients per year for 2.5 years. The successful offeror will need to exhibit the availability of staff, facilities, and institutional support necessary to conduct clinical trials on females, using FDA approved medications. The offeror will also have to evidence that he/she has a current and ready supply of female bipolar patients whose case histories are know to them and will be able to conduct clinical investigation in a prompt and cost-effective manner. It is anticipated that a 2.5 year cost reimbursement (completion) type contract will be awarded. INQUIRIES Request for Proposal (RFP) No. NIMH-96-CR-0006 will be available on or about June 15, 1996, with proposals due on or about July 31, 1996. All responsible sources may submit a proposal that will be considered by the NIMH. Telephone or verbal requests will not be honored. All requests for the RFP must cite the RFP number and be made in writing or by FAX request to: Patricia L. Gibbons Contract Management Branch National Institute of Mental Health 5600 Fishers Lane, Room 9C-15 Rockville, MD 20857 FAX: (301) 443-0143 .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||